The largest database of trusted experimental protocols

Pjet 1.2 blunt end cloning vector

Manufactured by Thermo Fisher Scientific
Sourced in United States

The PJET 1.2 blunt-end cloning vector is a plasmid-based system designed for the cloning of blunt-ended DNA fragments. It provides a simple and efficient method for the insertion of PCR products and other DNA segments with flush ends into a circular plasmid backbone.

Automatically generated - may contain errors

3 protocols using pjet 1.2 blunt end cloning vector

1

SARS-CoV-2 Genome Sequencing and Phylogenetic Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reverse transcription-polymerase chain reaction (RT-PCR) was performed to amplify the viral RNA for sequencing and phylogenetic analysis. Viral RNA was extracted using TRIzolTM Reagent (Thermo Fisher Scientific, USA) and amplified in one reaction with reverse transcriptase M-MLV (RNase H-), recombinant RNase inhibitor (TaKaRa, Japan) and the oligonucleotide universal primer 5’-AGCAAAAGCAGG-3’. The genome was amplified by PCR using the PlatinumTM Pfx DNA polymerase kit (Thermo Fisher Scientific, USA) with a series of primers[22 (link)]. The products were then purified using an agarose gel DNA purification kit (TaKaRa, Japan). To sequence the genes, the products were cloned into the pJET 1.2 blunt-end cloning vector (Thermo Fisher Scientific, USA) and transformed into competent DH5α (Tiangen Biotech Beijing Co., Ltd.). At least three clones per gene were sequenced by Sanger sequencing (Thermo Fisher Scientific, USA).
+ Open protocol
+ Expand
2

Antibody V-Region Cloning and Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA from ANA positive hybridomas was extracted using TRI Reagent (Sigma) followed by cDNA synthesis (GoScript Reverse Transcriptase) according to the manufacturer’s protocol and using primers as specified in Table S5 in Supplementary Material. Amplification of the heavy and light chain V-regions was performed using Vent polymerase (New England Biolabs) and, subsequently, the Vh and Vl regions were ligated into the pJet1.2 blunt end cloning vector (Thermo Fisher Scientific). For sequencing, plasmids were sent to Microsynth (Balgach, Switzerland). Resulting sequences were inspected using DNASTAR and aligned to the germline heavy and light chain sequences of the international ImMunoGeneTics information system® (http://imgt.org).
+ Open protocol
+ Expand
3

Cloning and Sequencing of ToBRFV Genome

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 1.5 µg total RNA extracted from inoculated N. clevelandii was subjected to cDNA synthesis using Maxima H Minus Reverse Transcriptase and random hexamers (Thermo Scientific™, Waltham, MA, USA) following the manufacturer’s protocol. The cDNAs were applied as a template in PCR for amplification of the genomic region of ToBRFV from nucleotides 1482-6393 (numbers are based on the GenBank accession number NC028478) in three segments using the primer pairs of ToBRFV-1482-s/ToBRFV-4750-as, ToBRFV-KpnI-4388-s/ToBRFV-HindIII-6153-as, and ToBRFV-CP-Eco47-s/ToBRFV-HindIII-3UTR-as, and Phusion™ High-Fidelity DNA Polymerase kit (Thermo Scientific, Waltham, MA, USA). PCR products were gel extracted and were inserted into pJET1.2 Blunt end cloning vector (Thermo Scientific, Waltham, MA, USA) in three steps through compatible DNA restriction sites available in the ToBRFV genome, the vector, and the primers. The final recombinant plasmid was named pJET-ToBRFV-1482-6393. The recombinant plasmids were sent to Macrogen (Macrogen Europe, Amsterdam, The Netherlands) for sequencing, and each nucleotide was sequenced at least twice. This plasmid was used as a template for the preparation of the plasmid standard curve in RT-qPCR and in vitro transcription.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!